Cupertino, CA, United States of America

Miguel Guzman

USPTO Granted Patents = 12 

Average Co-Inventor Count = 4.6

ph-index = 6

Forward Citations = 51(Granted Patents)


Location History:

  • Cupertino, CA (US) (2017 - 2019)
  • Los Gatos, CA (US) (2019 - 2020)

Company Filing History:


Years Active: 2017-2020

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Miguel Guzman: Innovator in Neuromodulatory Compounds

Introduction

Miguel Guzman is a prominent inventor based in Cupertino, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of neuromodulatory compounds. With a total of 12 patents to his name, Guzman's work is paving the way for innovative treatments for various medical conditions.

Latest Patents

Guzman's latest patents include groundbreaking inventions such as "Polycyclic Compounds and Uses Thereof." This invention provides novel neuromodulatory compounds and compositions, along with methods for treating various diseases and disorders. Another notable patent is "Ergoline Compounds and Uses Thereof," which details ergoline compounds and their pharmaceutical compositions. This patent outlines methods for treating medical disorders, including migraines, and discusses the agonizing and antagonizing of specific receptors using these compounds.

Career Highlights

Guzman is currently associated with Xoc Pharmaceuticals, Inc., where he continues to innovate and develop new pharmaceutical solutions. His work has garnered attention in the scientific community, contributing to advancements in medical treatments.

Collaborations

Guzman collaborates with notable colleagues such as Thomas A. Armer and Scott Borland, enhancing the research and development efforts at Xoc Pharmaceuticals.

Conclusion

Miguel Guzman's contributions to the field of pharmaceuticals through his innovative patents are noteworthy. His work in neuromodulatory compounds is set to impact the treatment of various medical conditions significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…